Tarsus Pharmaceuticals (TARS) Interest Coverage Ratio (2022 - 2026)

Tarsus Pharmaceuticals' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 2.88 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 75.77% year-over-year to 2.88; the TTM figure through Mar 2026 stood at 5.74 (up 52.25% YoY), while the FY2025 annual figure was 7.94, up 48.29% from the prior year.
• Interest Coverage Ratio was 2.88 for Q1 2026 at Tarsus Pharmaceuticals, up from 3.6 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 2.88 in Q1 2026 to a low of 61.78 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 24.02 across 5 years, with a median of 15.79 in 2024.
• The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio plunged 319.36% in 2023, then jumped 78.43% in 2024.
• A 5-year view of Interest Coverage Ratio shows it stood at 21.76 in 2022, then tumbled by 106.5% to 44.94 in 2023, then soared by 76.5% to 10.56 in 2024, then jumped by 65.89% to 3.6 in 2025, then climbed by 20.14% to 2.88 in 2026.
• The last three Interest Coverage Ratio figures came in at 2.88 (Q1 2026), 3.6 (Q4 2025), and 6.41 (Q3 2025), per Business Quant data.